The week in health tech, explained in plain English.Get the free newsletter →
October 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Health IT

Why Fragmented Data Is Stalling Healthcare AI Ambitions

Healthcare's AI ambitions are running ahead of its data. As Healthcare Dive reports, the core obstacle to scaling artificial intelligence across health systems is not the models themselves but the fragmented, siloed, and inconsistent data those models depend on. Patient information sits scattered across electronic health records, billing systems, labs, and imaging platforms, often in formats that do not talk to one another.

In practice, that means AI tools trained or deployed on messy data produce unreliable outputs, stalling projects at the pilot stage. The organizations moving fastest are the ones investing first in the unglamorous work: cleaning, standardizing, and connecting data before layering intelligence on top. A strong data foundation is what turns AI from a demo into dependable clinical and operational action.

The takeaway for executives is sequencing. Buying an AI product does not fix underlying data problems, and skipping the foundation guarantees disappointing returns. Data governance, interoperability, and quality control are prerequisites, not afterthoughts, for any health system serious about AI at scale.

More in Health IT

Health IT

Epic Opens Its Platform Wider to AI and Outside Developers

Epic used its Open@Epic developer conference to open its platform wider to outside AI and apps while reminding developers that the resulting traffic runs on hospitals' infrastructure.

Why it matters: As the dominant EHR vendor, Epic's decision to open its platform shapes how and where clinical AI gets deployed across most U.S. hospitals.

Health IT

After AI Go-Live, Who Owns Monitoring? Often No One

Health systems scrutinize AI before go-live, but post-deployment monitoring responsibilities often remain undefined, leaving no clear owner when models drift.

Why it matters: Unmonitored AI models can quietly degrade in clinical settings, putting patient safety at risk when no one is accountable for watching performance after launch.